Harry Mobley with current or former postdoctoral fellows. Left to right: Surbhi Gupta (University of Michigan), Laura Mike (University of Pittsburgh), Harry Mobley (University of Michigan), Melanie Pearson (University of Michigan), Chelsie Armbruster (SUNY Buffalo), and Allyson Shea (University of South Alabama)
Harry Mobley, Ph.D., was awarded the inaugural Lifetime Achievement Award from the Urinary Tract Infection Global Alliance (UTIGA). The ceremony took place on Friday, July 19, 2024, at the 5th Clinical and Scientific Advances in Urinary Tract Infections conference in Columbus, Ohio.The event was introduced by former Mobley Lab postdoc, and current Associate Professor at SUNY Buffalo, Chelsie Armbruster, Ph.D.. Additional comments were provided in absentia by former postdoc Sargarunathan Subashchandrabose, Ph.D., now Associate Professor at Texas A&M.
Dr. Mobley presented a retrospective on his distinguished 40-year career, which spans 20 years at the University of Maryland and 20 years at the University of Michigan. With a nod to his work in Helicobacter pylori and Proteus mirabilis, the remainder of the talk focused on his substantial contributions to the field of uropathogenic Escherichia coli (UPEC). He further explained what sets UPEC apart from other E. coli. This work included research about many virulence factors that contribute to establishing and maintaining UTI, such as adherence, motility, and iron acquisition. Mobley also described his group's work into measuring bacterial gene expression, remarkably high growth rates, and metabolism during UTI from women, both during "uncomplicated" bladder infection (cystitis) and more recently in postmenopausal women. Using the cumulative knowledge from these studies, he and his lab tested UTI vaccine formulations in mice. Despite the detail in this paragraph, this is only a snapshot of Harry's many contributions to the field.
Congratulations, Dr. Mobley!
Article written by Melanie Pearson, Ph.D.
Well-Being at Michigan Medicine
Dr. Elizabeth Harry welcomes Chip Amoe, U-M Health’s Chief Sustainability Officer, who shares how his Michigan roots and passion for revitalizing communities inspired his career in health care sustainability.
Health Lab
Acute pancreatitis is among the most common gastrointestinal conditions requiring inpatient hospital care in the United States. Balancing the signaling of the interleukin-22 protein and interleukin-22 binding protein is crucial to recovery from acute and chronic pancreatitis.
Department News
What I’m Reading in APS Research, written by Dr. Ajay Tambralli, was created to provide information about some of the latest APS research and to help everyone better understand the ins and outs of new discoveries. In this month’s edition, Dr. Tambralli explores the amazing properties of camelid antibodies and their potential applications in future therapies.
Department News
In M&I, we study adaptive immunology, also known as acquired immunology. The adaptive system is highly specific in that it distinguishes between different agents, recognizes a previously encountered agent, and adapts its response accordingly. When that agent is a pathogen, the adaptive response can help to clear that infection. A key feature of adaptive immunity is the development of immunological memory. This is the biology behind vaccines.
Department News
Biological Chemistry PhD student Zoe Yeoh of the Janet Smith and Melanie Ohi labs defends her doctoral dissertation.
Health Lab
Living close to cyanobacterial harmful algal blooms — which are present nationwide but are more common in coastal and Great Lake states — heightens the rate of dying from amyotrophic lateral sclerosis, or ALS, a study suggests.
